The Impact of the Covid-19 Pandemic on New and Ongoing Clinical Trials
Navigating the COVID-19 Pandemic, Preparing for the Rest of 2020 & Planning a Return to "Normalcy" in the New Clinical Trial Landscape 

June 25 - 26, 2020 | Virtual Event

Diane Maloney

Associate Director Policy, Center for Biologics Evaluation and Research (CBER) Food and Drug Administration (FDA)

Check out the incredible speaker line-up to see who will be joining Diane.

Download The Latest Agenda